Modified Orbital Decompression in the Treatment of Moderate-to-severe Grave's Ophthalmopathy
Modified Deep Lateral Wall Decompression and/or Deep Medial Wall Decompression for Moderate-to-severe Grave's Ophthalmopathy: a Prospective Study
Sun Yat-sen University
50 participants
Sep 1, 2024
INTERVENTIONAL
Conditions
Summary
To investigate the efficacy and safety of modified deep lateral wall decompression and/or medial wall decompression for Moderate-to-severe Grave's Ophthalmopathy.
Eligibility
Inclusion Criteria4
- EUGOGO/NOSPECS grade was moderate-to-severe thyroid associate ophthalmopathy;
- CAS≤3 score;
- stable thyroid function for at least 6 months;
- able and willing to participate in clinical trials and ensure regular follow-up;
Exclusion Criteria4
- any uncontrollable clinical problems (severe mental, neurological, cardiovascular, respiratory and other systemic diseases and malignant tumors);
- B-ultrasound or CT, MRI found other diseases causing exophthalmos (intraorbital space occupying lesion, inflammatory pseudotumor, neurofibroma, etc.);
- uveitis, glaucoma, high myopia, diabetic retinopathy and other eye diseases
- those who were considered by the researchers to be excluded
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Modified deep lateral orbital wall decompression is based on traditional outer wall decompression with combined abrasion of the deep outer orbital wall (including the greater pterygoid wing) to achieve adequate enlargement of the orbital cavity.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06588764